Thursday 5 December 2019: The Health Information and Quality Authority (HIQA) has today published a health technology assessment (HTA) recommending that the Minister for Health and the Health Service Executive (HSE) consider extending transcatheter aortic valve implantation (TAVI) — a minimally-invasive alternative to open heart surgery — to patients with severe symptomatic aortic stenosis at intermediate and low risk of surgical complications in the Irish public health care system.
HIQA undertook this HTA at the request of the HSE. Currently TAVI is primarily offered as an alternative to surgical aortic valve replacement (SAVR) in patients that are otherwise inoperable or at high risk of surgical complications.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
